Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice

Author:

Ohba Takuya1,Yoshino Yuta1,Ishisaka Mitsue1,Abe Naohito2,Tsuruma Kazuhiro1,Shimazawa Masamitsu1,Oyama Masayoshi2,Tabira Takeshi34,Hara Hideaki1

Affiliation:

1. Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

2. Pharmacognosy, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan

3. Department of Diagnosis, Prevention and Treatment of Dementia, Graduate School of Medicine, Juntendo University, Tokyo, Japan

4. Kawamura Hospital, Gifu, Japan

Abstract

Abstract Huperzia serrata has been used as a Chinese folk medicine for many years. It contains huperzine A, which has a protective effect against memory deficits in animal models; however, it is unclear if H. serrata extract exerts any effects in Alzheimer’s disease (AD) models. We used H. serrata collected in Japan and determined its huperzine A content using HPLC. We determined its inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity. H. serrata extract (30 mg/kg/day) and donepezil (10 mg/kg/day) were orally administrated for 7 days. After repeated administration, we performed the Y-maze and passive avoidance tests. H. serrata extract contained 0.5% huperzine A; H. serrata extract inhibited AChE, but not BuChE. H. serrata extract ameliorated cognitive function in mice. These results indicate that Japanese H. serrata extract ameliorates cognitive function deficits by inhibiting AChE. Therefore, H. serrata extract may be valuable for the prevention or treatment of dementia in AD.

Publisher

Oxford University Press (OUP)

Subject

Organic Chemistry,Molecular Biology,Applied Microbiology and Biotechnology,General Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Reference31 articles.

1. Alzheimer’s disease: a current review;Watson;Can. Fam. Physician,1984

2. Network-based biomarkers in Alzheimer’s disease: review and future directions;Gomez-Ramirez;Front. Aging Neurosci,2014

3. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity;Takashima;Proc. Natl. Acad. Sci. USA,1993

4. The cholinergic hypothesis of Alzheimer’s disease: a review of progress;Francis;J. Neurol. Neurosurg. Psychiatry,1999

5. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer’s disease;Kar;J. Psychiatry Neurosci,2004

Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Therapeutic Approach of Phytomedicine for Dementia: A Review;Current Traditional Medicine;2024-10

2. Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents;Neuroscience;2024-05

3. Some promising medicinal plants used in Alzheimer’s disease: an ethnopharmacological perspective;Discover Applied Sciences;2024-04-16

4. Preparation and evaluation of transdermal permeation of Huperzine A ethosomes gel in vitro;BMC Pharmacology and Toxicology;2024-02-26

5. Anti-Alzheimer drugs: A state of art;INTERNATIONAL CONFERENCE ON HUMANS AND TECHNOLOGY: A HOLISTIC AND SYMBIOTIC APPROACH TO SUSTAINABLE DEVELOPMENT: ICHT 2022;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3